Protocadherin-7 contributes to maintenance of bone homeostasis through regulation of osteoclast multinucleation
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Osteoclasts are hematopoietic-derived cells that resorb bone. They are required to maintain proper bone homeostasis and skeletal strength. Although osteoclast differentiation depends on receptor activator of NF-B ligand (RANKL) stimulation, additional molecules further contribute to osteoclast maturation. Here, we demonstrate that protocadherin-7 (Pcdh7) regulates formation of multinucleated osteoclasts and contributes to maintenance of bone homeostasis. We found that Pcdh7 expression is induced by RANKL stimulation, and that RNAi-mediated knockdown of Pcdh7 resulted in impaired formation of osteoclasts. We generated Pcdh7-deficient mice and found increased bone mass due to decreased bone resorption but without any defect in bone formation. Using an in vitro culture system, it was revealed that formation of multinucleated osteoclasts is impaired in Pcdh7-deficient cultures, while no apparent defects were observed in differentiation and function of Pcdh7-deficient osteoblasts. Taken together, these results reveal an osteoclast cell-intrinsic role for Pcdh7 in maintaining bone homeostasis.
Abstract
Osteoclasts are hematopoietic-derived cells that resorb bone. They are required to maintain proper bone homeostasis and skeletal strength. Although osteoclast differentiation depends on receptor activator of NF-B ligand (RANKL) stimulation, additional molecules further contribute to osteoclast maturation. Here, we demonstrate that protocadherin-7 (Pcdh7) regulates formation of multinucleated osteoclasts and contributes to maintenance of bone homeostasis. We found that Pcdh7 expression is induced by RANKL stimulation, and that RNAi-mediated knockdown of Pcdh7 resulted in impaired formation of osteoclasts. We generated Pcdh7-deficient mice and found increased bone mass due to decreased bone resorption but without any defect in bone formation. Using an in vitro culture system, it was revealed that formation of multinucleated osteoclasts is impaired in Pcdh7-deficient cultures, while no apparent defects were observed in differentiation and function of Pcdh7-deficient osteoblasts. Taken together, these results reveal an osteoclast cell-intrinsic role for Pcdh7 in maintaining bone homeostasis.
참고문헌 (27)
- Teitelbaum SL, "Genetic regulation of osteoclast development and function", Nat Rev Genet, 4, pp.638~649 (2003)
- Moutsopoulos NM, "Defective neutrophil recruitment in leukocyte adhesion deficiency type I disease causes local IL-17-driven inflammatory bone loss", Sci Transl Med, 6, pp.229ra40~ (2014)
- Souza PP, "The role of cytokines in inflammatory bone loss", Immunol Invest, 42, pp.555~622 (2013)
- Takayanagi H, "Osteoimmunology : shared mechanisms and crosstalk between the immune and bone systems", Nat Rev Immunol, 7, pp.292~304 (2007)
- Walsh MC, "Osteoimmunology : interplay between the immune system and bone metabolism", Annu Rev Immunol, 24, pp.33~63 (2006)
- Boyle JW, "Osteoclast differentiation and activation", Nature, 423, pp.337~342 (2003)
- Aguilar PS, "Genetic basis of cell-cell fusion mechanisms", Trends Genet, 29, pp.427~437 (2013)
- Kim H, "The purinergic receptor P2X5 regulates inflammasome activity and hyper-multinucleation of murine osteoclasts", Sci Rep, 7, pp.196~ (2017)
- Takeichi M, "Dynamic contacts : rearranging adherens junctions to drive epithelial remodelling", Nat Rev Mol Cell Biol, 15, pp.397~410 (2014)
- Leckband DE, "Cadherin adhesion and mechanotransduction", Annu Rev Cell Dev Biol, 30, pp.291~315 (2014)
- Hayashi S, "Emerging roles of protocadherins : from self-avoidance to enhancement of motility", J Cell Sci, 128, pp.1455~1464 (2015)
- Kim SY, "Non-clustered protocadherin", Cell Adh Migr, 5, pp.97~105 (2011)
- Peek SL, "Regulation of neural circuit formation by protocadherins", Cell Mol Life Sci, 74, pp.4133~4157 (2017)
- Nakamura H, "Global epigenomic analysis indicates protocadherin-7activates osteoclastogenesis by promoting cell-cell fusion", Biochem Biophys Res Commun, 455, pp.305~311 (2014)
- Helming L, "Molecular mediators of macrophage fusion", Trends Cell Biol, 19, pp.514~522 (2009)
- Oren-Suissa M, "Cell fusion during development", Trends Cell Biol, 17, pp.537~546 (2007)
- Kim H, "IgSF11regulates osteoclast differentiation through association with the scaffold protein PSD-95", Bone Res, 8, pp.5~ (2020)
- Kahr I, "Delta-protocadherins in health and disease", Prog Mol Biol Transl Sci, 116, pp.169~192 (2013)
- Heggem M, "The cytoplasmic domain of Xenopus NF-protocadherin interacts with TAF1", set, 2003, pp.4, 419~429
- Bradley R, "NF-protocadherin, a novel member of the cadherin superfamily, is required for Xenopus ectodermal differentiation", Curr Biol, 8, pp.325~334 (1998)
- Zhou X, "PROTOCA DHERIN 7 Acts through SET and PP2A to Potentiate MAPK Signaling by EGFR and KRAS during Lung Tumorigenesis", Cancer Res, 77, pp.187~197 (2017)
- Wang L, "Protein phosphatase 2A as a new target for downregulating osteoclastogenesis and alleviating titanium particle-induced bone resorption", Acta Biomater, 73, pp.488~499 (2018)
- Vanhalst K, "delta-Protocadherins : a gene family expressed differentially in the mouse brain", Cell Mol Life Sci, 62, pp.1247~1259 (2005)
- Zaidi M, "Skeletal remodeling in health and disease", Nat Med, 13, pp.791~801 (2007)
- Matsuo K, "Osteoclast-osteoblast communication", Arch Biochem Biophys, 473, pp.201~209 (2008)
- Miyazaki T, "A review of denosumab for the treatment of osteoporosis", Patient Prefer Adherence, 8, pp.463~471 (2014)
- Baron R, "Denosumab and bisphosphonates : different mechanisms of action and effects", Bone, 48, pp.677~692 (2011)